Molecular docking and ADMET properties of natural products against the Cathepsin D, in breast cancer

Breast cancer is the most recurrent cancer among women, and according to statistics reported by WHO, it impacts 2.1 million women each year and causes death among women. Cathepsin D(CD), one of the attractive targets in the treatment of breast cancer, has been implicated in HIV neuropathogenesis with potential proteolytic effectson chemokines.